BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38212880)

  • 1. Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal study.
    Sogabe M; Okahisa T; Kagawa M; Sei M; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
    J Gastroenterol Hepatol; 2024 Apr; 39(4):754-761. PubMed ID: 38212880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population.
    Liu J; Lin H; Zhang C; Wang L; Wu S; Zhang D; Tang F; Xue F; Liu Y
    BMC Gastroenterol; 2014 Dec; 14():213. PubMed ID: 25496394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
    Kim NH; Kang JH; Kim HJ
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
    Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.
    Zhu Q; Sun X; Ji X; Zhu L; Xu J; Wang C; Zhang C; Xue F; Liu Y
    Sci Rep; 2016 Jul; 6():29937. PubMed ID: 27443986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome as a risk factor for gallstone disease.
    Méndez-Sánchez N; Chavez-Tapia NC; Motola-Kuba D; Sanchez-Lara K; Ponciano-Rodríguez G; Baptista H; Ramos MH; Uribe M
    World J Gastroenterol; 2005 Mar; 11(11):1653-7. PubMed ID: 15786544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of abdominal adiposity and gallstone disease in US men.
    Tsai CJ; Leitzmann MF; Willett WC; Giovannucci EL
    Am J Clin Nutr; 2004 Jul; 80(1):38-44. PubMed ID: 15213025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
    Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
    BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
    Sogabe M; Okahisa T; Kagawa M; Sei M; Ueda H; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Kawano Y; Miyamoto H; Sato Y; Nakasono M; Takayama T
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1107-1114. PubMed ID: 38419514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
    Ruhl CE; Everhart JE
    Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.
    Acalovschi M; Buzas C; Radu C; Grigorescu M
    J Viral Hepat; 2009 Dec; 16(12):860-6. PubMed ID: 19486279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study.
    Sogabe M; Okahisa T; Kagawa M; Ueda H; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Taniguchi T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
    Clin Nutr; 2023 May; 42(5):810-816. PubMed ID: 37043935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.
    Yilmaz Y; Ayyildiz T; Akin H; Colak Y; Ozturk O; Senates E; Tuncer I; Dolar E
    Gut Liver; 2014 May; 8(3):313-7. PubMed ID: 24827629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
    Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic biomarkers and gallstone disease - a population-based study.
    Shabanzadeh DM; Skaaby T; Sørensen LT; Eugen-Olsen J; Jørgensen T
    Scand J Gastroenterol; 2017 Nov; 52(11):1270-1277. PubMed ID: 28799434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver increases gallstone disease risk in younger Chinese patients.
    Li X; Gao P
    Medicine (Baltimore); 2019 May; 98(22):e15940. PubMed ID: 31145367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.